What is AN2 Therapeutics Inc?
, a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease, as well as studying for the treatment of acute melioidosis. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 198.07M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 820,325 shares $117k | 12,098 shares $12k |
| 3-6months | 441,612 shares $239k | 0 |
| 6-9months | 1327 shares $347 | 0 |
| 9-12months | 642,784 shares $43k | 0 |